Revance Therapeutics, Inc. (RVNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
31 Pages - GLDATA56157
$250.00

Summary

Revance Therapeutics, Inc. (Revance) is a bio-pharmaceutical company that develops, manufactures and commercializes novel botulinum toxin products for multiple aesthetic and therapeutic applications. The company’s products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. Its TransMTS, a platform technology delivers botulinum toxin and other potent macromolecules across skin without patches. Revance also provides RT002, a next-generation injectable BoNT-A product. The company serves in various therapeutic areas including orthopedics, neurology and pain management, among others. Revance is headquartered in Newark, California, the US.

Revance Therapeutics, Inc. (RVNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Revance Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Revance Therapeutics Raises US$10 Million In Venture Financing 12
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 13
Revance Therapeutics Secures US$40 Million In Venture Financing 15
ReVance Therapeutics Secures US$5 Million In Financing Round 17
Licensing Agreements 18
Revance Therapeutics Terminates Licensing Agreement With Medicis Pharma For Neurotoxins 18
Equity Offering 19
Revance Therapeutics Plans to Raise up to USD75 Million in Public Offering of Shares 19
Revance Therapeutics Prices Public Offering of Shares for USD117 Million 21
Revance Therapeutics to Raise USD50 Million in Public Offering of Common Stock 23
Revance Therapeutics Raises USD140.3 Million in Public Offering of Shares 24
Revance Therapeutics Completes IPO For US$110.4 Million 26
Revance Therapeutics, Inc. - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Revance Therapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Revance Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Revance Therapeutics Raises US$10 Million In Venture Financing 12
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 13
Revance Therapeutics Secures US$40 Million In Venture Financing 15
ReVance Therapeutics Secures US$5 Million In Financing Round 17
Revance Therapeutics Terminates Licensing Agreement With Medicis Pharma For Neurotoxins 18
Revance Therapeutics Plans to Raise up to USD75 Million in Public Offering of Shares 19
Revance Therapeutics Prices Public Offering of Shares for USD117 Million 21
Revance Therapeutics to Raise USD50 Million in Public Offering of Common Stock 23
Revance Therapeutics Raises USD140.3 Million in Public Offering of Shares 24
Revance Therapeutics Completes IPO For US$110.4 Million 26
Revance Therapeutics, Inc., Key Competitors 28
Revance Therapeutics, Inc., Key Employees 29
Revance Therapeutics, Inc., Subsidiaries 30

List of Figures
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Revance Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Revance Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838